Sponsor Pipeline

C4 Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07284758
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With…		 Trial sites expanded: 10 -> 21 locations
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07284758 A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With… Multiple Myeloma Recruiting
Phase 1
NCT07280013 A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in… Multiple Myeloma (MM) Recruiting
NCT04756726 Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory… Multiple Myeloma Active, Not Recruiting
Disease Areas
Multiple Myeloma (3)
Get alerts when C4 Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free